Details for New Drug Application (NDA): 214757
✉ Email this page to a colleague
The generic ingredient in LEVETIRACETAM is levetiracetam. There are thirty-five drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.
Summary for 214757
Tradename: | LEVETIRACETAM |
Applicant: | Msn |
Ingredient: | levetiracetam |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 214757
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 214757
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEVETIRACETAM | levetiracetam | SOLUTION;ORAL | 214757 | ANDA | MAJOR PHARMACEUTICALS | 0904-7420 | 0904-7420-16 | 473 mL in 1 BOTTLE, PLASTIC (0904-7420-16) |
LEVETIRACETAM | levetiracetam | SOLUTION;ORAL | 214757 | ANDA | Novadoz Pharmaceuticals LLC | 72205-037 | 72205-037-72 | 473 mL in 1 BOTTLE, PLASTIC (72205-037-72) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | 100MG/ML | ||||
Approval Date: | Jul 15, 2022 | TE: | AA | RLD: | No |
Complete Access Available with Subscription